+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cyclic Peptides Market - Global Forecast 2026-2032- Product Image
Cyclic Peptides Market - Global Forecast 2026-2032- Product Image
Sale

Cyclic Peptides Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083542
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cyclic Peptides Market is projected to reach USD 3.57 Billion in 2026. It is expected to continue growing at a CAGR of 6.63%, reaching USD 5.27 Billion by 2032.

Cyclic Peptides: Executive Summary and Strategic Context

Cyclic peptides are peptide-based molecules whose ring structure can improve conformational stability, target recognition, and resistance to enzymatic degradation relative with many linear peptides. Their distinctive balance between biological specificity and molecular design flexibility supports investigation across therapeutic discovery, targeted delivery, diagnostics, and research applications. The field remains scientifically complex, with development outcomes shaped by target validation, synthesis, formulation, pharmacokinetics, safety, and regulatory requirements.

How Molecular Engineering Is Reshaping Cyclic Peptide Development

The cyclic peptide landscape is being transformed by advances in peptide synthesis, structure-guided design, screening, and drug-delivery technologies. Researchers are combining backbone and side-chain cyclization with noncanonical amino acids, constrained scaffolds, and computational design to address selectivity, stability, permeability, and manufacturability challenges. Progress also depends on integrated analytical workflows that confirm purity, stereochemistry, conformational behavior, and biological activity throughout development.

Artificial Intelligence Accelerates Discovery While Preserving Experimental Rigor

Artificial intelligence is increasingly applied to sequence generation, structure prediction, virtual screening, property optimization, and interpretation of high-throughput experimental data. In cyclic peptides, these tools can help prioritize candidates with desirable binding, stability, permeability, and developability characteristics, reducing inefficient iteration. However, model quality depends on representative training data and rigorous laboratory validation; explainability, data governance, intellectual-property controls, and reproducibility remain essential for responsible adoption.

Regional Insights: Distributed Capabilities Across Six Development Hubs

North America combines strong biomedical research infrastructure, venture activity, advanced screening, and regulatory experience. Europe benefits from coordinated scientific networks, specialized peptide chemistry, and established translational capabilities. Asia-Pacific is supported by expanding biopharmaceutical research, manufacturing capacity, and growing investment in advanced modalities. Latin America is developing research and clinical capabilities, while regulatory and manufacturing maturity varies by country. The Middle East is strengthening life-science infrastructure and innovation programs, and Africa presents emerging opportunities alongside constraints involving specialized talent, financing, laboratory capacity, and access to advanced technologies.

Group Insights: Collaboration Shapes Research and Commercial Readiness

ASEAN economies are developing complementary capabilities in pharmaceutical manufacturing, research, and clinical development, though infrastructure differs across members. BRICS countries contribute substantial scientific, manufacturing, and patient-population resources, with collaboration influenced by distinct regulatory and investment environments. The European Union benefits from shared regulatory coordination and cross-border research networks. G7 members provide deep expertise in discovery science, clinical development, and advanced manufacturing. GCC states are investing in health infrastructure and diversification, while NATO countries collectively represent important research, procurement, and biotechnology ecosystems despite differing national policies.

Country Insights: Diverse Strengths Across the Required National Markets

Australia contributes strong biomedical research and clinical capabilities; Brazil and Mexico provide important Latin American research, healthcare, and manufacturing bases. Canada and the United States combine advanced discovery, translational science, and biotechnology infrastructure. China, Japan, India, and South Korea offer substantial research, pharmaceutical manufacturing, and technology capabilities, with Japan also bringing extensive experience in peptide science. France, Germany, Italy, Spain, and the United Kingdom contribute specialized academic, industrial, clinical, and regulatory expertise. Russia maintains scientific and pharmaceutical capabilities, although collaboration, investment, and access to international technologies can be affected by geopolitical and regulatory conditions.

Priorities for Leaders: Build a Disciplined Cyclic Peptide Innovation Platform

Industry leaders should prioritize validated disease biology, differentiated molecular design, and early assessment of stability, permeability, immunogenicity, formulation, and scalable synthesis. Cross-functional teams should connect medicinal chemistry, computational modeling, analytics, pharmacology, toxicology, clinical development, and regulatory strategy from the outset. Organizations can improve resilience through diversified supply chains, qualified manufacturing partners, robust quality systems, and regional regulatory planning. Artificial intelligence should be deployed with curated datasets, documented validation protocols, human oversight, and clear decision criteria tied to experimental outcomes.

Research Methodology: Evidence-Based Assessment of Cyclic Peptide Dynamics

This executive summary uses a structured qualitative assessment of cyclic peptide science, development practices, enabling technologies, regional ecosystems, country capabilities, and policy considerations. The approach emphasizes verifiable evidence from peer-reviewed research, regulatory publications, clinical-trial records, public institutional materials, and documented industry practices. Findings are synthesized thematically rather than expressed through market estimates, forecasts, shares, or company-specific claims. Regional, group, and country comparisons reflect observable differences in infrastructure, research depth, manufacturing capability, investment conditions, and regulatory coordination.

Conclusion: Translational Execution Will Determine Cyclic Peptide Progress

Cyclic peptides offer a versatile platform for addressing biological targets that can be difficult to reach with conventional small molecules or larger biologics. Continued progress will depend on connecting molecular innovation with reliable synthesis, delivery, safety evaluation, clinical evidence, and regulatory execution. Organizations that combine disciplined experimentation, responsible artificial intelligence, regional collaboration, and resilient manufacturing practices will be better positioned to convert promising cyclic peptide concepts into useful therapies and research tools.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cyclic Peptides Market, by Type
7.1. Introduction
7.2. Natural Cyclic Peptide
7.3. Synthetic Cyclic Peptide
8. Cyclic Peptides Market, by Product Type
8.1. Introduction
8.2. Antimicrobial Peptides
8.2.1. Daptomycin
8.2.2. Gramicidin S
8.2.3. Tyrocidine
8.3. Hormonal Peptides
8.3.1. Oxytocin
8.3.2. Somatostatin
8.3.3. Vasopressin
8.4. Immunomodulating Peptides
8.5. Peptide Vaccines
9. Cyclic Peptides Market, by Technology
9.1. Introduction
9.2. Chemical Synthesis
9.3. Liquid-Phase Synthesis
9.4. Recombinant DNA Technology
9.5. Solid-Phase Synthesis
10. Cyclic Peptides Market, by Purity Grade
10.1. Introduction
10.2. Below 90%
10.3. 90% To 98%
10.4. Above 98%
11. Cyclic Peptides Market, by Application
11.1. Introduction
11.2. Agriculture
11.3. Cosmetics
11.4. Diagnostics
11.4.1. Biosensors
11.4.2. Immunoassays
11.5. Research & Development
11.5.1. Biochemical Analysis
11.5.2. Drug Discovery
11.5.3. Molecular Biology
11.6. Therapeutics
11.6.1. Cardiovascular
11.6.2. Infectious Diseases
11.6.3. Metabolic Disorders
11.6.4. Oncology
12. Cyclic Peptides Market, by End User
12.1. Introduction
12.2. Academic Institutes
12.3. Biotechnology Firms
12.4. Pharmaceutical Companies
13. Cyclic Peptides Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. Europe
13.4. North America
13.5. Latin America
13.6. Africa
13.7. Middle East
14. Cyclic Peptides Market, by Group
14.1. Introduction
14.2. NATO
14.3. G7
14.4. European Union
14.5. BRICS
14.6. ASEAN
14.7. GCC
15. Cyclic Peptides Market, by Country
15.1. Introduction
15.2. United States
15.3. China
15.4. Germany
15.5. Canada
15.6. India
15.7. Japan
15.8. United Kingdom
15.9. Brazil
15.10. Mexico
15.11. France
15.12. Italy
15.13. Australia
15.14. South Korea
15.15. Russia
15.16. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Bachem AG
17.2. Thermo Fisher Scientific Inc.
17.3. Merck & Co., Inc.
17.4. AstraZeneca PLC
17.5. Clariant AG
17.6. Genscript Biotech Corporation
17.7. Kaneka Corporation
17.8. Corden Pharma International GmbH
17.9. BioDuro LLC
17.10. Zealand Pharma A/S
17.11. Neuland Laboratories Ltd
17.12. JPT Peptide Technologies GmbH
17.13. TCG Lifesciences Pvt. Ltd.
17.14. Biosynth Ltd
17.15. Eli Lilly and Company
17.16. Almac Group Ltd.
17.17. AmbioPharm, Inc.
17.18. Aurigene Pharmaceutical Services by Dr. Reddy's Laboratories Ltd.
17.19. Biopharma PEG Scientific Inc
17.20. LifeTein LLC
17.21. Novartis AG
17.22. Pfizer Inc.
17.23. Sanofi S.A.
17.24. SciTide LLC
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cyclic Peptides Market, Years Considered for the Study
FIGURE 2. Global Cyclic Peptides Market, Research Design
FIGURE 3. Global Cyclic Peptides Market, Research Framework
FIGURE 4. Global Cyclic Peptides Market, Data Triangulation
FIGURE 5. Global Cyclic Peptides Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cyclic Peptides Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Cyclic Peptides Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cyclic Peptides Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Cyclic Peptides Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cyclic Peptides Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Cyclic Peptides Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cyclic Peptides Market Size, by Purity Grade, 2025 vs 2032 (%)
FIGURE 13. Global Cyclic Peptides Market Size, by Purity Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cyclic Peptides Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Cyclic Peptides Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cyclic Peptides Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Cyclic Peptides Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cyclic Peptides Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Cyclic Peptides Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Cyclic Peptides Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Cyclic Peptides Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Cyclic Peptides Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Cyclic Peptides Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cyclic Peptides Market Segmentation & Coverage
TABLE 2. Global Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Natural Cyclic Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Natural Cyclic Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Natural Cyclic Peptide Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Synthetic Cyclic Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Synthetic Cyclic Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Synthetic Cyclic Peptide Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 11. Global Antimicrobial Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Antimicrobial Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Antimicrobial Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Daptomycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Daptomycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Daptomycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Gramicidin S Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Gramicidin S Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Gramicidin S Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Tyrocidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Tyrocidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Tyrocidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Hormonal Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Hormonal Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Hormonal Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Oxytocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Oxytocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Oxytocin Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Somatostatin Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Somatostatin Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Somatostatin Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Vasopressin Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Vasopressin Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Vasopressin Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Immunomodulating Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Immunomodulating Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Immunomodulating Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Peptide Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Peptide Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Peptide Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 42. Global Chemical Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Chemical Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Chemical Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Liquid-Phase Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Liquid-Phase Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Liquid-Phase Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Recombinant DNA Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Recombinant DNA Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Recombinant DNA Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Solid-Phase Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Solid-Phase Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Solid-Phase Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 55. Global Below 90% Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Below 90% Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Below 90% Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global 90% To 98% Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global 90% To 98% Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global 90% To 98% Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Above 98% Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Above 98% Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Above 98% Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Global Agriculture Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Agriculture Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Agriculture Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Cosmetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Cosmetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Cosmetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Biosensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Biosensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Biosensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Research & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Research & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Research & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Biochemical Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Biochemical Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Biochemical Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Molecular Biology Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Molecular Biology Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Molecular Biology Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Biotechnology Firms Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Biotechnology Firms Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Biotechnology Firms Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Europe Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Europe Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 132. Europe Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Europe Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 134. Europe Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 135. Europe Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. Europe Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 137. Europe Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Europe Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 139. Europe Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 140. Europe Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 141. Europe Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. North America Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. North America Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 144. North America Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. North America Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 146. North America Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 147. North America Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. North America Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 149. North America Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. North America Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 151. North America Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 152. North America Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 153. North America Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Latin America Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Latin America Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 156. Latin America Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. Latin America Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 158. Latin America Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 159. Latin America Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. Latin America Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 161. Latin America Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Latin America Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 163. Latin America Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 164. Latin America Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 165. Latin America Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Africa Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Africa Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 168. Africa Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Africa Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 170. Africa Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 171. Africa Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. Africa Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 173. Africa Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Africa Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 175. Africa Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 176. Africa Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 177. Africa Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Middle East Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Middle East Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 180. Middle East Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. Middle East Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 182. Middle East Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 183. Middle East Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. Middle East Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 185. Middle East Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Middle East Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 187. Middle East Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 188. Middle East Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 189. Middle East Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Global Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. NATO Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. NATO Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 193. NATO Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 194. NATO Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 195. NATO Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 196. NATO Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 197. NATO Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 198. NATO Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. NATO Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 200. NATO Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 201. NATO Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 202. NATO Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. G7 Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. G7 Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 205. G7 Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. G7 Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 207. G7 Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 208. G7 Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. G7 Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 210. G7 Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. G7 Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 212. G7 Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 213. G7 Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 214. G7 Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. European Union Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. European Union Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 217. European Union Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. European Union Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 219. European Union Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 220. European Union Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. European Union Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 222. European Union Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. European Union Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 224. European Union Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 225. European Union Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 226. European Union Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. BRICS Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. BRICS Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 229. BRICS Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. BRICS Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 231. BRICS Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 232. BRICS Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 233. BRICS Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 234. BRICS Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. BRICS Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 236. BRICS Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 237. BRICS Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 238. BRICS Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. ASEAN Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. ASEAN Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 241. ASEAN Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. ASEAN Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 243. ASEAN Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 244. ASEAN Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. ASEAN Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 246. ASEAN Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. ASEAN Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 248. ASEAN Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 249. ASEAN Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 250. ASEAN Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. GCC Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. GCC Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 253. GCC Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. GCC Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 255. GCC Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 256. GCC Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. GCC Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 258. GCC Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. GCC Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 260. GCC Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 261. GCC Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 262. GCC Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Global Cyclic Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 264. United States Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 265. United States Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 266. United States Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 267. United States Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 268. United States Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 269. United States Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 270. United States Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 271. United States Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. United States Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 273. United States Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 274. United States Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 275. United States Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. China Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 277. China Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 278. China Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. China Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 280. China Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 281. China Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 282. China Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 283. China Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. China Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 285. China Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 286. China Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 287. China Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. Germany Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 289. Germany Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 290. Germany Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. Germany Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 292. Germany Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 293. Germany Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. Germany Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 295. Germany Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. Germany Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 297. Germany Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 298. Germany Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 299. Germany Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. Canada Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 301. Canada Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 302. Canada Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 303. Canada Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 304. Canada Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 305. Canada Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 306. Canada Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 307. Canada Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. Canada Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 309. Canada Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 310. Canada Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 311. Canada Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. India Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 313. India Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 314. India Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 315. India Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 316. India Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 317. India Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 318. India Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 319. India Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. India Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 321. India Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 322. India Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 323. India Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. Japan Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 325. Japan Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 326. Japan Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 327. Japan Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 328. Japan Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 329. Japan Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 330. Japan Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 331. Japan Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. Japan Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 333. Japan Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 334. Japan Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 335. Japan Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. United Kingdom Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 337. United Kingdom Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 338. United Kingdom Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. United Kingdom Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 340. United Kingdom Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 341. United Kingdom Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 342. United Kingdom Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 343. United Kingdom Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 344. United Kingdom Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 345. United Kingdom Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 346. United Kingdom Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 347. United Kingdom Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 348. Brazil Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 349. Brazil Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 350. Brazil Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 351. Brazil Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 352. Brazil Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 353. Brazil Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 354. Brazil Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 355. Brazil Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 356. Brazil Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 357. Brazil Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 358. Brazil Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 359. Brazil Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 360. Mexico Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 361. Mexico Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 362. Mexico Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 363. Mexico Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 364. Mexico Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 365. Mexico Cyclic Peptides Market Size, by Technology, 2017-2032 (USD Million)
TABLE 366. Mexico Cyclic Peptides Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 367. Mexico Cyclic Peptides Market Size, by Application, 2017-2032 (USD Million)
TABLE 368. Mexico Cyclic Peptides Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 369. Mexico Cyclic Peptides Market Size, by Research & Development, 2017-2032 (USD Million)
TABLE 370. Mexico Cyclic Peptides Market Size, by Therapeutics, 2017-2032 (USD Million)
TABLE 371. Mexico Cyclic Peptides Market Size, by End User, 2017-2032 (USD Million)
TABLE 372. France Cyclic Peptides Market Size, 2017-2032 (USD Million)
TABLE 373. France Cyclic Peptides Market Size, by Type, 2017-2032 (USD Million)
TABLE 374. France Cyclic Peptides Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 375. France Cyclic Peptides Market Size, by Antimicrobial Peptides, 2017-2032 (USD Million)
TABLE 376. France Cyclic Peptides Market Size, by Hormonal Peptides, 2017-2032 (USD Million)
TABLE 377. France Cyclic Peptides Market Size, by Technology, 2017

Companies Mentioned

  • Bachem AG
  • Thermo Fisher Scientific Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Clariant AG
  • Genscript Biotech Corporation
  • Kaneka Corporation
  • Corden Pharma International GmbH
  • BioDuro LLC
  • Zealand Pharma A/S
  • Neuland Laboratories Ltd
  • JPT Peptide Technologies GmbH
  • TCG Lifesciences Pvt. Ltd.
  • Biosynth Ltd
  • Eli Lilly and Company
  • Almac Group Ltd.
  • AmbioPharm, Inc.
  • Aurigene Pharmaceutical Services by Dr. Reddy's Laboratories Ltd.
  • Biopharma PEG Scientific Inc
  • LifeTein LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SciTide LLC

Related Topics

Related Reports

Cyclic Peptide Library Market - Global Forecast 2026-2032 - Product Image

Cyclic Peptide Library Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032 - Product Image

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2026 - Product Image

G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cyclic Diadenosine Monophosphate (CAS 54447-84-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Cyclic Diadenosine Monophosphate (CAS 54447-84-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Propyleneglycol Cyclic Carbonate (CAS 108-32-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Propyleneglycol Cyclic Carbonate (CAS 108-32-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.